Basics Revolution Medicines, Inc. IPO Date: February 13, 2020 Sector: Healthcare Industry: Biotech Market Cap: $7.04B Activated in VL: True Average Daily Range Avg Daily Range: $0.82 | 2.71% Avg Daily Range (30 D): $0.74 | 1.90% Avg Daily Range (90 D): $0.79 | 2.10% Institutional Daily Volume Avg Daily Volume: .83M Avg Daily Volume (30 D): 1.59M Avg Daily Volume (90 D): 1.52M Trade Size Avg Trade Size (Sh.): 70 Avg Trade Size (Sh.) (30 D): 66 Avg Trade Size (Sh.) (90 D): 63 Institutional Trades Total Inst.Trades: 4,400 Avg Inst. Trade: $3.11M Avg Inst. Trade (30 D): $6.22M Avg Inst. Trade (90 D): $4.8M Avg Inst. Trade Volume: .09M Avg Inst. Trades (Per Day): 3 Market Closing Trades Avg Closing Trade: $5.79M Avg Closing Trade (30 D): $22.12M Avg Closing Trade (90 D): $14.31M Avg Closing Volume: 178.73K     News Jun 27, 2025 @ 11:00 AM Tango Therapeutics Announces First Patient Dosed i... Source: Tango Therapeutics May 27, 2025 @ 1:00 PM rEvolution Appoints Brian Gabriel as Vice Presiden... Source: Globe Newswire May 12, 2025 @ 11:00 AM Tango Therapeutics Reports First Quarter 2025 Fina... Source: N/A Apr 27, 2025 @ 4:05 PM Revolution Medicines Presents Initial Data from Zo... Source: N/A Jul 16, 2024 @ 12:16 PM Top 3 Health Care Stocks That Should Keep You Up A... Source: Avi Kapoor Financials   TTM Q1 2025 Q4 2024 Basic EPS $-4.01 $-1.13 $-1.13 Diluted EPS $-4.01 $-1.13 $-1.13 Revenue $ M $ M $ M Gross Profit $ $ $ Net Income / Loss $ -697.51M $ -213.42M $ -194.57M Operating Income / Loss $ -789.43M $ -240.76M $ -216.31M Cost of Revenue $ $ $ Net Cash Flow $ 45.79M $ -209.51M $ 342.61M PE Ratio